Treatment options for patients with brain metastases from EGFR/ALK-driven lung cancer.
Doherty MK, Korpanty GJ, Tomasini P, Alizadeh M, Jao K, Labbé C, Mascaux CM, Martin P, Kamel-Reid S, Tsao MS, Pintilie M, Liu G, Bradbury PA, Feld R, Leighl NB, Chung C, Shepherd FA.
Doherty MK, et al. Among authors: chung c.
Radiother Oncol. 2017 May;123(2):195-202. doi: 10.1016/j.radonc.2017.03.007. Epub 2017 Mar 28.
Radiother Oncol. 2017.
PMID: 28363487